Literature DB >> 19806260

Pneumococcal association to platelets is mediated by soluble fibrin and supported by thrombospondin-1.

Silke Niemann1, Beate E Kehrel, Christine Heilmann, Claudia Rennemeier, Georg Peters, Sven Hammerschmidt.   

Abstract

Platelets and coagulation are involved in bacterial colonisation of the host. Streptocococcus pneumoniae (pneumococcus) are important etiologic agents of respiratory tract infections in humans. The formation of pneumococci-platelet associations may facilitate haematogenous dissemination of pneumococci by providing an adhesive surface on damaged endothelium. However, the formation of platelet-pneumococci associations and the factors involved in this process have not been described so far. The formation of platelet-pneumococci associates was analysed and quantified using flow cytometry. Binding of pneumococci to platelets was significantly increased after activation of platelets with thrombin, while platelet activation by ADP or collagen did not promote formation of platelet-pneumococci associates. In addition to be a platelet agonist, thrombin cleaves fibrinogen, which results in the generation of fibrin. The simultaneous formation of fibrin and activation of platelets was shown to be a prerequisite for a high number of platelet-pneumococci associates. Moreover, exogenously added human thrombospondin-1 (TSP-1) significantly enhanced the association of pneumococci with activated platelets. Soluble fibrin and TSP-1 are key co-factors of platelet-pneumococci-association. Similar results were recently demonstrated for S. aureus-platelet adhesion. Consequently, we hypothesise that the described mechanism of platelet-bacteria-association might represent a general and important strategy of Gram-positive bacteria during development of invasive diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19806260     DOI: 10.1160/TH09-01-0049

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

Review 1.  [Pathophysiology and biochemistry of platelets].

Authors:  K Jurk; B E Kehrel
Journal:  Internist (Berl)       Date:  2010-09       Impact factor: 0.743

2.  Pneumococcal Adhesins PavB and PspC Are Important for the Interplay with Human Thrombospondin-1.

Authors:  Ulrike Binsker; Thomas P Kohler; Krystin Krauel; Sylvia Kohler; Hansjörg Schwertz; Sven Hammerschmidt
Journal:  J Biol Chem       Date:  2015-04-20       Impact factor: 5.157

Review 3.  Contribution of Human Thrombospondin-1 to the Pathogenesis of Gram-Positive Bacteria.

Authors:  Ulrike Binsker; Thomas P Kohler; Sven Hammerschmidt
Journal:  J Innate Immun       Date:  2019-02-27       Impact factor: 7.349

4.  Pathogenic characterization of a cervical lymph node derived from a patient with Kawasaki disease.

Authors:  Harutaka Katano; Seiichi Sato; Tsuyoshi Sekizuka; Akiko Kinumaki; Hitomi Fukumoto; Yuko Sato; Hideki Hasegawa; Shigeru Morikawa; Masayuki Saijo; Tetsuya Mizutani; Makoto Kuroda
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

Review 5.  Subterfuge and sabotage: evasion of host innate defenses by invasive gram-positive bacterial pathogens.

Authors:  Cheryl Y M Okumura; Victor Nizet
Journal:  Annu Rev Microbiol       Date:  2014-06-18       Impact factor: 15.500

6.  Repeating structures of the major staphylococcal autolysin are essential for the interaction with human thrombospondin 1 and vitronectin.

Authors:  Thomas P Kohler; Nicolas Gisch; Ulrike Binsker; Martin Schlag; Katrin Darm; Uwe Völker; Ulrich Zähringer; Sven Hammerschmidt
Journal:  J Biol Chem       Date:  2013-12-26       Impact factor: 5.157

7.  Endogenous thrombospondin-1 regulates leukocyte recruitment and activation and accelerates death from systemic candidiasis.

Authors:  Gema Martin-Manso; Dhammika H M L P Navarathna; Susana Galli; David R Soto-Pantoja; Svetlana A Kuznetsova; Maria Tsokos; David D Roberts
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

Review 8.  Platelets, Bacterial Adhesins and the Pneumococcus.

Authors:  Kristin Jahn; Thomas P Kohler; Lena-Sophie Swiatek; Sergej Wiebe; Sven Hammerschmidt
Journal:  Cells       Date:  2022-03-25       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.